Stockreport

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

Beta Bionics, Inc.  (BBNX) 
PDF IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, [Read more]